Pharmaceuticals

Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

by

More Patients Added to Phase 1 Trial Following Encouraging Early Results ROCHESTER, Minn., June 14, 2023 /PRNewswire/ — Vyriad, Inc., announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the safety and efficacy of Voyager-V1 (VSV-hIFNbeta-NIS) in patients with peripheral T-cell lymphoma (PTCL) following encouraging initial results1. Voyager-V1 is an investigational therapy … Read more

Joseph C. Papa Joins Water Street Healthcare Partners

by

CHICAGO, June 14, 2023 /PRNewswire/ — Water Street Healthcare Partners announced today that Joseph C. Papa has joined its team of senior investment professionals and executives dedicated to growing health care businesses. Mr. Papa, former chairman and CEO of Bausch and Lomb, will spearhead the health care firm’s search for its next investment in the specialty … Read more

Lake Regional Health System enters prime vendor agreement with Medline

by

Missouri-based health system and Medline expand partnership to optimize supply chain NORTHFIELD, Ill., June 13, 2023 /PRNewswire/ — Medline today announced a multi-year prime vendor distribution agreement with Missouri-based Lake Regional Health System. The two organizations began working together in early 2022, when Medline was selected as the system’s partner for all surgical procedure trays. After being … Read more

Tetra Pharm Technologies annonce la réussite du test in vitro de libération d’un nouveau composé analgésique

by

La société de biotechnologie danoise Tetra Pharm Technologies annonce les résultats prometteurs des essais précliniques de son médicament antidouleur – TPT0301. COPENHAGUE, Danemark, 13 juin 2023 /PRNewswire/ — Dans une récente étude in vitro du TPT0301, la nouvelle technologie d’administration de médicaments de Tetra Pharm Technologies a été comparée à des formules plus couramment utilisées pour … Read more

LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA

by

BURLINGTON, N.C., June 12, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”): The record date will be 5:00 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and … Read more

Alexander Shulgin Research Institute Announces Formation of Scientific Advisory Board and Identification of Two Lead Compounds at Psychedelic Science 2023

by

Lead compounds show remarkable efficacy and safety profiles LAFAYETTE, Calif., June 12, 2023 /PRNewswire/ — Alexander Shulgin Research Institute (ASRI), a pioneering organization in the discovery of next generation psychedelic medicines, announces the identification of two lead compounds currently undergoing late-stage preclinical testing. ASRI plans to disclose further details of their initial lead compounds in a … Read more

Рекордное количество участников на 20-й выставке CACLP и 3-й выставке CISCE в Нанчане

by

НАНЧАН, Китай, 12 июня 2023 г. /PRNewswire/ — С 28 по 30 мая 2023 г. в Нанчане, Китай, прошла 20-я выставка Китайской ассоциации клинической лабораторной практики (CACLP) и 3-я Китайская выставка IVD Supply Chain Expo (CISCE), признанные ведущими выставка диагностики in vitro (IVD) в мире. PR1 На выставочной площади в 130 000 кв. м приняли … Read more

Translumina bolsters its German presence with acquisition of Lamed GmbH

by

NEW DELHI and MUNICH, June 12, 2023 /PRNewswire/ — Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further towards its stated goal of providing a comprehensive cardiovascular portfolio at scale across … Read more

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

by

— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced clinical data for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual … Read more

Increasing Prevalence of Diseases is a Major Driver

by

DUBLIN, June 2, 2023 /PRNewswire/ — The “Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global small molecule active pharmaceutical ingredient market is expected to grow from $167.59 billion … Read more